Metabolite formation pharmacokinetics: rate and extent of metabolite formation determined by deconvolution
- PMID: 2469080
- DOI: 10.1023/a:1015951426191
Metabolite formation pharmacokinetics: rate and extent of metabolite formation determined by deconvolution
Abstract
A two-step analytic procedure to determine the rate and extent of metabolite production following administration of the parent compound is described. The procedure provides the rate and extent of metabolite production as a function of time by application of the general model independent approach of deconvolution. The metabolite unit impulse response function is obtained by implicit deconvolution of the metabolite data with a truncated constant-rate metabolite input function. Then the obtained unit impulse response function is used in an analytic deconvolution with metabolite data following administration of the parent compound to obtain the rate and extent of metabolite production. The input function is also deconvolved with metabolite data to obtain the unit impulse response function appropriate for prediction of metabolite levels given a selected input of parent compound. The expected profile following administration of the consecutive infusions of parent drug is shown for both parent and metabolite. The rationale for selection of deconvolution methods is discussed. The approach is applied to data for procainamide and N-acetylprocainamide from three human subjects. The results indicate that from 27 to 39% of the procainamide was converted to N-acetylprocainamide in these subjects.
Similar articles
-
Pharmacokinetics of procainamide and N-acetylprocainamide in rats.J Pharm Sci. 1981 Mar;70(3):299-302. doi: 10.1002/jps.2600700319. J Pharm Sci. 1981. PMID: 6167709
-
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.Am J Cardiol. 1980 Sep;46(3):463-8. doi: 10.1016/0002-9149(80)90016-8. Am J Cardiol. 1980. PMID: 6158263 Clinical Trial.
-
The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part I. Procainamide and its active metabolite-N-acetylprocainamide.Acta Pol Pharm. 1995 Mar-Apr;52(2):141-6. Acta Pol Pharm. 1995. PMID: 8960244
-
Clinical pharmacokinetics of N-acetylprocainamide.Clin Pharmacokinet. 1982 May-Jun;7(3):206-20. doi: 10.2165/00003088-198207030-00002. Clin Pharmacokinet. 1982. PMID: 6178545 Review.
-
[Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].Przegl Lek. 1984;41(5):379-83. Przegl Lek. 1984. PMID: 6206523 Review. Polish. No abstract available.
Cited by
-
Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans.Pharm Res. 1994 Jun;11(6):824-30. doi: 10.1023/a:1018969506143. Pharm Res. 1994. PMID: 7937520 Clinical Trial.
-
The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.Pharm Res. 1992 Apr;9(4):464-8. doi: 10.1023/a:1015828027060. Pharm Res. 1992. PMID: 1495890
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical